Tuesday, March 02, 2010

Commercial Compliance for Pharmaceutical and Medical Device Companies

Date Posted: 02/22/2010 
Size: 5.62MB 
Length: 00:12:17 
Thought Leader: Daniel Garen, Chief Compliance Officer and Senior Counsel, Siemens Healthcare Sector, USA

In an exclusive interview with PharmaVOICE, Mr. Garen shares his expertise and insights on a variety of commercial compliance issues, including The Sunshine Act, Healthcare Reform, the Foreign Corrupt Practices Act (FCPA), and how companies can create a culture of compliance through proactivity. Mr. Garen is also the keynote speaker at the upcoming Marcus Evans' Commercial Compliance for Pharmaceutical and Medical Device Companies Conference, April 12-13, Washington, D.C. For more information about the conference, please go to: http://www.marcusevansch.com/commericalcompliance.


For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

No comments: